Getinge AB Class B GNGBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $25.00
- Day Range
- $23.39–23.39
- 52-Week Range
- $20.05–25.00
- Bid/Ask
- $25.83 / $28.09
- Shares Outstanding
- 272.37M
- Market Cap
- $6.37B
- Volume/Avg
- 151 / 129
Key Statistics
- Price/Earnings (Normalized)
- 18.54
- Price/Sales
- 1.74
- Dividend Yield (Trailing)
- 2.20%
- Dividend Yield (Forward)
- 2.20%
- Dividend Payment Schedule
- Apr
- Total Yield
- 2.20%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,758
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
GNGBF
|
MDT
|
SYK
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.54 | 17.07 | 22.01 |
Price/Book Value | 1.95 | 2.46 | 4.91 |
Price/Sales | 1.74 | 3.31 | 4.59 |
Price/Cash Flow | 11.29 | 13.86 | 21.02 |
Price/Earnings
GNGBF
MDT
SYK
Financial Strength
|
Metric
|
GNGBF
|
MDT
|
SYK
|
|---|---|---|---|
Quick Ratio | 0.72 | 1.29 | 1.08 |
Current Ratio | 1.25 | 2.07 | 2.16 |
Interest Coverage | 7.91 | 10.12 | — |
Quick Ratio
GNGBF
MDT
SYK
Profitability
|
Metric
|
GNGBF
|
MDT
|
SYK
|
|---|---|---|---|
Return on Assets (Normalized) | 6.11% | 8.31% | 11.44% |
Return on Equity (Normalized) | 11.50% | 15.59% | 23.97% |
Return on Invested Capital (Normalized) | 9.40% | 10.57% | 14.10% |
Return on Assets
GNGBF
MDT
SYK
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<jF?#BQ | LOCK|?!Z%& | $177B | |||
| Medtronic PLC
MDT
| LOCK|!f<sj& | LOCK|s>gr? | $124B | |||
| Stryker Corp
SYK
| LOCK|@^Mhg?c | LOCK|q&p | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|G!<RP< | LOCK|lzgrr | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|Q>TFPC& | LOCK|&LQWd | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Z>?V@< | LOCK|SS | $32B | |||
| DexCom Inc
DXCM
| LOCK|%h&^m&# | LOCK|qJ>< | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|&$@ | LOCK|&?< | $26B | |||
| Steris PLC
STE
| LOCK|nw?b<H! | LOCK|dNDn! | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|TkjKsW>! | LOCK|F! | $19B |
United States